Blood cell test aims to spot lung cancer sooner
NCT ID NCT03992183
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a type of cell in the blood, called CAMLs, can help find early-stage lung cancer in people with suspicious lung nodules. Researchers planned to enroll 200 adults with nodules that had not yet been biopsied. The trial was terminated early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY NODULE, MULTIPLE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Corporal Michael J. Crescenz VA Medical Center
Philadelphia, Pennsylvania, 19104, United States
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which dye or gas best maps lung segments? a Head-to-Head test
- AI-Powered navigation aims to pinpoint tiny lung nodules during surgery
- New 3D lung mapping could replace needle punctures for small nodule surgery
- AI matches radiologists in reading chest X-Rays, study finds
- AI could help doctors spot lung cancer earlier, avoid unnecessary biopsies
- Robot rumble: which machine does lung surgery better and cheaper?